Specialty code 183500000X · Panorama City, CA
NPI
1508959362
Since 2006
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
13652 Cantara St
Panorama City, CA, 91402
Phone (818) 375-2443
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$263K
1,273 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Anna H Chung prescribed most often to Medicare patients was Humulin N Kwikpen (Insulin Nph Human Isophane), with 134 prescriptions and refills. In total Anna H Chung wrote 1,273 Medicare prescriptions that cost $263K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Humulin N Kwikpen Insulin Nph Human Isophane | 134 | 348 | 56 | $30K |
| Glipizide Generic | 120 | 381 | 59 | $1,703 |
| Metformin Hcl Er Metformin Hcl | 117 | 390 | 61 | $1,136 |
| Ozempic Semaglutide | 115 | 121 | 30 | $85K |
| Atorvastatin Calcium Generic | 93 | 310 | 49 | $1,119 |
| Metformin Hcl Generic | 75 | 250 | 38 | $966 |
| Jardiance Empagliflozin | 71 | 196 | 30 | $48K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 70 | 212 | 35 | $2,041 |
| Glipizide Er Glipizide | 65 | 215 | 31 | $2,309 |
| Humulin N Insulin Nph Human Isophane | 65 | 190 | 29 | $14K |
| Insulin Glargine-Yfgn Generic | 37 | 104 | 21 | $6,418 |
| Lisinopril Generic | 32 | 107 | 14 | $400 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 26 | 77 | Under 11 | $501 |
| Victoza 3-Pak Liraglutide | 24 | 30 | Under 11 | $21K |
| Humalog Kwikpen U-100 Insulin Lispro | 24 | 64 | 12 | $7,513 |
Brand drugs: 545 claims; generic drugs: 612 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Anna H Chung were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.